Guido Moll

5.9k total citations · 2 hit papers
50 papers, 3.4k citations indexed

About

Guido Moll is a scholar working on Genetics, Surgery and Hematology. According to data from OpenAlex, Guido Moll has authored 50 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 18 papers in Surgery and 13 papers in Hematology. Recurrent topics in Guido Moll's work include Mesenchymal stem cell research (27 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Tissue Engineering and Regenerative Medicine (10 papers). Guido Moll is often cited by papers focused on Mesenchymal stem cell research (27 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Tissue Engineering and Regenerative Medicine (10 papers). Guido Moll collaborates with scholars based in Germany, Sweden and United States. Guido Moll's co-authors include Olle Ringdén, Katarina Le Blanc, Lena von Bahr, Julian Kamhieh‐Milz, Sven Geißler, Petra Reinke, James A. Ankrum, Hans‐Dieter Volk, Berit Sundberg and Karen Bieback and has published in prestigious journals such as Blood, PLoS ONE and Journal of Virology.

In The Last Decade

Guido Moll

48 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation

2012 425 citations Lena von Bahr, Guido Moll et al. profile →
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines

2019 295 citations Guido Moll, James A. Ankrum et al. Trends in Molecular Medicine profile →

Peers

Countries citing papers authored by Guido Moll

Since Specialization

Citations

This map shows the geographic impact of Guido Moll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Moll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Moll more than expected).

Fields of papers citing papers by Guido Moll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Moll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Moll. The network helps show where Guido Moll may publish in the future.

Co-authorship network of co-authors of Guido Moll

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Moll. A scholar is included among the top collaborators of Guido Moll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Moll. Guido Moll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	165 The neuroimmunological network in cancer-induced HPV Infections 2024 ·Clinical Immunology ·(unknown), (unknown), Fernando Ĺ. Vale, Dennyson Leandro M. Fonseca, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vanderson Rocha, Guido Moll, Helder I. Nakaya, Igor Salerno Filgueiras, (unknown)	0
2	Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery 2023 ·Frontiers in Immunology ·(unknown), (unknown), Igor Salerno Filgueiras, Dennyson Leandro M. Fonseca, Irene Hinterseher, Rusan Catar, Raghavan Chinnadurai, Alexey Bersenev, Otávio Cabral-Marques, Guido Moll, Frances Verter	20
3	Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α signaling 2023 ·Frontiers in Immunology ·Guido Moll, (unknown), (unknown), Dennyson Leandro M. Fonseca, (unknown), Hongfan Zhao, (unknown), Lei Chen, Muhammad Imtiaz Ashraf, Harald Heidecke, Alexander Hackel, Duska Dragun, Klemens Budde, Olaf Penack, Gabriela Riemekasten, Otávio Cabral-Marques, Janusz Witowski, Rusan Catar	4
4	Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism 2023 ·Frontiers in Immunology ·Hongfan Zhao, (unknown), (unknown), (unknown), (unknown), (unknown), Muhammad Imtiaz Ashraf, Julian Kamhieh‐Milz, Janusz Witowski, Duska Dragun, Klemens Budde, Ralf Schindler, Daniel Zickler, Guido Moll, Rusan Catar	7
5	Neuroimmunology of rabies: New insights into an ancient disease 2023 ·Journal of Medical Virology ·(unknown), (unknown), (unknown), (unknown), (unknown), Dennyson Leandro M. Fonseca, (unknown), (unknown), Igor Salerno Filgueiras, Lena F. Schimke, Lasse M. Giil, Guido Moll, Gustavo Cabral‐Miranda, H D Ochs, Pedro Fernando da Costa Vasconcelos, Guilherme Dias de Melo, Hervé Bourhy, Lívia Medeiros Neves Casseb, Otávio Cabral-Marques	12
6	Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization 2023 ·Frontiers in Immunology ·(unknown), Desirée Rodrigues Plaça, Dennyson Leandro M. Fonseca, Alexandre H. C. Marques, Igor Salerno Filgueiras, (unknown), (unknown), (unknown), Mário Hiroyuki Hirata, Paula Paccielli Freire, Rusan Catar, Gustavo Cabral‐Miranda, Lena F. Schimke, Guido Moll, Otávio Cabral-Marques	3
7	Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk Factors, and Non-HLA Antibodies in Heart Transplant Recipients: A Pilot Study 2023 ·Journal of Clinical Medicine ·Dorota Sikorska, Dorota Kamińska, Rusan Catar, (unknown), Hongfan Zhao, (unknown), Julian Kamhieh‐Milz, Mirosław Banasik, Mariusz Kusztal, (unknown), Michał Zakliczyńśki, (unknown), Katarzyna Korybalska, Harald Heidecke, Guido Moll, Włodzimierz Samborski	5
8	Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy 2022 ·Frontiers in Immunology ·Rusan Catar, Maria Bartosova, Edyta Kawka, Lei Chen, (unknown), (unknown), Hongfan Zhao, (unknown), Daniel Zickler, (unknown), Marek Karczewski, Julian Kamhieh‐Milz, Achim Jörres, Guido Moll, Claus Peter Schmitt, Janusz Witowski	16
9	Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells 2021 ·Biofabrication ·(unknown), Andrea Mazzocchi, Stephan Schlickeiser, Steven D. Forsythe, Guido Moll, Sven Geißler, Petra Reinke, Manfred Gossen, Vijay S. Gorantla, Hans‐Dieter Volk, Shay Söker	37
10	Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products ex vivo and in vivo 2021 ·Frontiers in Cell and Developmental Biology ·Daniel R. Kaiser, Natalie Otto, (unknown), (unknown), Ghazaleh Zarrinrad, Maik Stein, Carola Beier, (unknown), (unknown), Joanna Hester, Guido Moll, Fadi Issa, Petra Reinke, Andy Roemhild	19
11	MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy 2020 ·Frontiers in Immunology ·Guido Moll, (unknown), Julian Kamhieh‐Milz, Sven Geißler, Hans‐Dieter Volk, Petra Reinke	129
12	Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application 2019 ·Frontiers in Immunology ·Henry W. Caplan, Scott D. Olson, Akshita Kumar, Mitchell J. George, Karthik S. Prabhakara, Pamela L. Wenzel, Supinder S. Bedi, Naama E. Toledano Furman, Fabio Triolo, Julian Kamhieh‐Milz, Guido Moll, Charles S. Cox	226
13	Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines breakdown → 2019 ·Trends in Molecular Medicine ·Guido Moll, James A. Ankrum, Julian Kamhieh‐Milz, Karen Bieback, Olle Ringdén, Hans‐Dieter Volk, Sven Geißler, Petra Reinke	295
14	Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells 2019 ·Frontiers in Immunology ·Behnam Sadeghi, (unknown), Fabian Arnberg, Erik Samén, (unknown), Rusan Catar, Julian Kamhieh‐Milz, Sven Geißler, Guido Moll, Staffan Holmin, Olle Ringdén	25
15	Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis 2017 ·Frontiers in Immunology ·Arjang Baygan, (unknown), (unknown), (unknown), Göran Dahllöf, Lena Klingspor, Britt Gustafsson, (unknown), Guido Moll, (unknown), Britt‐Marie Svahn, Magnus Westgren, Mats Remberger, Behnam Sadeghi, Olle Ringdén	39
16	Effects of Freeze–Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 2016 ·Stem Cells and Development ·Martin J. Hoogduijn, S Witte, Franka Luk, (unknown), Lech Ignatowicz, Rusan Catar, Tanja Strini, Sander S. Korevaar, Wilfred F. J. van IJcken, Michiel G.H. Betjes, Marcella Franquesa, Guido Moll, Carla C. Baan	54
17	Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placenta Decidua 2015 ·Transplant International ·Guido Moll, Lech Ignatowicz, Rusan Catar, Behnam Sadeghi, Osama A. Hamad, Philipp Jungebluth, Artur Schmidtchen, Olle Ringdén, Duska Dragun	2
18	Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua 2015 ·Stem Cells and Development ·Guido Moll, Lech Ignatowicz, Rusan Catar, (unknown), Behnam Sadeghi, Osama A. Hamad, Philipp Jungebluth, Duska Dragun, Artur Schmidtchen, Olle Ringdén	99
19	Host-directed therapies for tuberculous pericarditis 2015 ·International Journal of Infectious Diseases ·Alimuddin Zumla, Markus Maeurer, Guido Moll, Bongani M. Mayosi	5
20	Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses 2011 ·PLoS ONE ·Guido Moll, Regina Jitschin, Lena von Bahr, (unknown), Berit Sundberg, (unknown), Graciela Elgue, Kristina Nilsson‐Ekdahl, Dimitrios Mougiakakos, John D. Lambris, Olle Ringdén, Katarina Le Blanc, Bo Nilsson	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact